Oppenheimer & CO Inc Sana Biotechnology, Inc. Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.24 - $15.58 $53,448 - $158,916	-10,200 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$15.18 - $23.15 $272,481 - $415,542	-17,950 Reduced 63.77%	10,200 $158,000
Q3 2021 Nov 12, 2021	SELL	$16.29 - $25.88 $14,661 - $23,292	-900 Reduced 3.1%	28,150 $634,000
Q2 2021 Aug 03, 2021	SELL	$16.65 - $32.14 $1,664 - $3,214	-100 Reduced 0.34%	29,050 $571,000
Q1 2021 May 10, 2021	BUY	$23.04 - $43.5 $671,616 - $1.27 Million	29,150 New	29,150 $976,000

173

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $601M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.